Jefferies Financial Group Inc's Dividend Analysis
Zealand Pharma Shares Attractive Ahead of Key Obesity Drug Data -- Market Talk
0901 GMT - Zealand Pharma's apparent share selloff on competitor data is an opportunity, in Jefferies's view. Zealand Pharma has a pipeline of obesity drugs and shares have risen 66% this year, but th
Express News | Italy sells shares in energy giant to reduce debt
Jefferies Financial To Go Ex-Dividend On May 17th, 2024 With 0.3 USD Dividend Per Share
May 16th - $Jefferies Financial(JEF.US)$ is trading ex-dividend on May 17th, 2024. Shareholders of record on May 20th, 2024 will receive 0.3 USD dividend per share on May 30th, 2024. The ex-divide
Jefferies Financial Group Insider Sold Shares Worth $12,974,358, According to a Recent SEC Filing
Brian P Friedman, Director, President, on May 13, 2024, sold 280,396 shares in Jefferies Financial Group (JEF) for $12,974,358. Following the Form 4 filing with the SEC, Friedman has control over a to
Jefferies Financial(JEF.US) Officer Sells US$12.97 Million in Common Stock
$Jefferies Financial(JEF.US)$ Officer FRIEDMAN BRIAN P sold 280.4K shares of common stock on May 13, 14, 2024 at an average price of $46.2716 for a total value of $12.97 million.Source: Announcement W
Form 144 | Jefferies Financial(JEF.US) Insider Proposes to Sell 7.6 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Jefferies Financial(JEF.US)$ Insider FRIEDMAN BRIAN P intends to sell 165.4K shares of its common stock on May 14, with a total market value of approximately $7.6 mill
Form 144 | Jefferies Financial(JEF.US) Insider Proposes to Sell 5.28 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 13, $Jefferies Financial(JEF.US)$ Insider FRIEDMAN BRIAN P intends to sell 115K shares of its common stock on May 13, with a total market value of approximately $5.28 milli
GE Aero Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 8.76% JP Morgan $148 → $175 Maintains Overweight 04/29/2024 19.32% Wells Fargo $165 → $192 Main
Kaiser Permanente to Sell Private-fund Stakes Due to Cash Constraints, WSJ Says
MEG Energy Seen Fairly Valued After In-Line Results -- Market Talk
0838 ET - Jefferies retains a hold call on MEG Energy in the wake of in-line 1Q results and unchanged guidance, with the analysts positive on the energy company for its pure-play oil sands exposure an
Jefferies Asks Judge to Remove Managers of Weiss Multi-Strategy
Express News | Jefferies downgraded XCMG's rating to holding.
Express News | Jefferies downgraded National Australia Bank's rating to the back of the market.
Unusual Options Activity: PYPL, CCJ and Others Attract Market Bets, PYPL V/OI Ratio Reaches 499.5
EST May 1st Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.Of
Have Insiders Sold Jefferies Financial Group Shares Recently?
Some Jefferies Financial Group Inc. (NYSE:JEF) shareholders may be a little concerned to see that the CEO & Director, Richard Handler, recently sold a substantial US$65m worth of stock at a price of U
Jefferies Financial Is Maintained at Outperform by Oppenheimer
Jefferies Financial Is Maintained at Outperform by Oppenheimer
Oppenheimer: Maintaining the Jefferies Financial Gr (JEF.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $54.00 to $56.00.
Oppenheimer: Maintaining the Jefferies Financial Gr (JEF.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $54.00 to $56.00.
Oppenheimer Maintains Outperform on Jefferies Financial Gr, Raises Price Target to $56
Oppenheimer analyst Chris Kotowski maintains Jefferies Financial Gr (NYSE:JEF) with a Outperform and raises the price target from $54 to $56.
Jefferies Financial Gr Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 28.21% Oppenheimer $54 → $56 Maintains Outperform 04/02/2024 23.63% Oppenheimer $52 → $54 Maint
No Data